跳至主要内容
临床试验/NCT01933360
NCT01933360已完成2 期

Sublingual Versus Vaginal Misoprostol for Cervical Dilatation 1 or 3 Hours Prior to Surgical Abortion

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 184 人开始时间: 2013年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
184
试验地点
1
主要终点
Force needed for cervical dilatation

研究概览

简要总结

Despite of the widespread use, and extensive studies, the optimal route of administration of misoprostol before surgical abortion remains to be defined. Following administration of 400 mcg vaginally as per clinical guidelines, the time for optimal priming seems to be 3 hours, but the longer the interval the greater the risk or bleeding and expulsion of the uterine contents before the surgical evacuation. Sublingual administration seems to give adequate plasma concentration and cervical priming faster than oral or vaginal administration. This may allow a shorter waiting time with maintained efficacy, less side effects and logistic advantages.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women opting for first trimester surgical abortion
  • nulliparous
  • able and willing to provide informed consent

排除标准

  • unwilling to participate,
  • unable to communicate in Swedish and English and
  • minors (i.e. women < 18 years of age),
  • contraindications to misoprostol
  • women with pathological pregnancies

研究组 & 干预措施

Misoprostol sublingual,1h

Active Comparator

Administration of misoprostol sublingually 1h prior to surgery

干预措施: Misoprostol sublingual, 1h (Drug)

Misoprostol sublingual,1h

Active Comparator

Administration of misoprostol sublingually 1h prior to surgery

干预措施: Placebo vaginal, 1h (Drug)

Misoprostol sublingual. 3h

Active Comparator

Administration of misoprostol sublingually 3h prior to surgery

干预措施: Misoprostol sublingual, 3h (Drug)

Misoprostol sublingual. 3h

Active Comparator

Administration of misoprostol sublingually 3h prior to surgery

干预措施: Placebo vaginal, 3h (Drug)

Misoprostol vaginal,1h

Active Comparator

Administration of misoprostol vaginally 1h prior to surgery

干预措施: Placebo sublingual,1h (Drug)

Misoprostol vaginal,1h

Active Comparator

Administration of misoprostol vaginally 1h prior to surgery

干预措施: Misoprostol vaginal, 1h (Drug)

Misoprostol vaginal,3h

Active Comparator

Administration of misoprostol vaginally 3h prior to surgery

干预措施: Misoprostol vaginal, 3h (Drug)

Misoprostol vaginal,3h

Active Comparator

Administration of misoprostol vaginally 3h prior to surgery

干预措施: Placebo sublingual, 3h (Drug)

结局指标

主要结局

Force needed for cervical dilatation

时间窗: Measured at surgery

Cervical dilation is evaluated at surgery using Hulka dilators connected to a tonometer. Force and time needed for the dilatation is recorded by the tonometer

次要结局

  • Cervical diameter(Measured at surgery)
  • Number of Participants with Adverse Events(Up to surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kristina Gemzell Danielsson

Professor

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验

Misoprostol for Cervical Priming Prior to Vacuum... | 临床试验